BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9784421)

  • 1. Activated rat stellate cells express c-met and respond to hepatocyte growth factor to enhance transforming growth factor beta1 expression and DNA synthesis.
    Ikeda H; Nagoshi S; Ohno A; Yanase M; Maekawa H; Fujiwara K
    Biochem Biophys Res Commun; 1998 Sep; 250(3):769-75. PubMed ID: 9784421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of c-met expression in rats with acute hepatic failure.
    Mizuguchi T; Kamohara Y; Hui T; Neuman T; Mitaka T; Demetriou AA; Rozga J
    J Surg Res; 2001 Aug; 99(2):385-96. PubMed ID: 11469916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte growth factor and c-Met expression in rat and human liver fibrosis.
    Cramer T; Schuppan D; Bauer M; Pfander D; Neuhaus P; Herbst H
    Liver Int; 2004 Aug; 24(4):335-44. PubMed ID: 15287857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The characteristics of hepatic stem cells and the expression of growth factor and their receptors in the early embryonic human liver].
    Jiang J; Li A; Zhou H; Mei Y; Yang S; Hong H; Song H; Yang H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Dec; 21(6):995-8. PubMed ID: 15646350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Met responsiveness of isolated hepatocytes evaluated in an in vitro de-differentiation model.
    Boost KA; Kim HJ; Engl T; Oppermann E; Jonas D; Oertl A; Blaheta RA
    Int J Mol Med; 2006 Mar; 17(3):475-82. PubMed ID: 16465395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the proliferative capability of hepatocytes and the intrahepatic expression of hepatocyte growth factor and c-Met in the course of cirrhosis development in rats.
    Inoue H; Yokoyama F; Kita Y; Yoshiji H; Tsujimoto T; Deguchi A; Nakai S; Morishita A; Uchida N; Masaki T; Watanabe S; Kuriyama S
    Int J Mol Med; 2006 May; 17(5):857-64. PubMed ID: 16596271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of experimental hepatic fibrosis by combinational delivery of urokinase-type plasminogen activator and hepatocyte growth factor genes.
    Lin Y; Xie WF; Chen YX; Zhang X; Zeng X; Qiang H; Chen WZ; Yang XJ; Han ZG; Zhang ZB
    Liver Int; 2005 Aug; 25(4):796-807. PubMed ID: 15998431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells.
    Arias M; Lahme B; Van de Leur E; Gressner AM; Weiskirchen R
    Cell Growth Differ; 2002 Jun; 13(6):265-73. PubMed ID: 12114216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive and inhibitory effects of simultaneous treatment with growth factors on DNA synthesis through MAPK pathway and G1 cyclins in rat hepatocytes.
    Moriuchi A; Hirono S; Ido A; Ochiai T; Nakama T; Uto H; Hori T; Hayashi K; Tsubouchi H
    Biochem Biophys Res Commun; 2001 Jan; 280(1):368-73. PubMed ID: 11162525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice: interactions between the periductal inflammatory and stromal cells and the biliary epithelium.
    Liu Z; Sakamoto T; Ezure T; Yokomuro S; Murase N; Michalopoulos G; Demetris AJ
    Hepatology; 1998 Nov; 28(5):1260-8. PubMed ID: 9794910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression and synthesis of fibronectin isoforms in rat hepatic stellate cells. Comparison with liver parenchymal cells and skin fibroblasts.
    Xu G; Niki T; Virtanen I; Rogiers V; De Bleser P; Geerts A
    J Pathol; 1997 Sep; 183(1):90-8. PubMed ID: 9370953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia: a potential mechanism for liver regeneration failure in experimental cirrhosis.
    Corpechot C; Barbu V; Wendum D; Chignard N; Housset C; Poupon R; Rosmorduc O
    Am J Pathol; 2002 Feb; 160(2):613-20. PubMed ID: 11839582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis.
    Kim WH; Matsumoto K; Bessho K; Nakamura T
    Am J Pathol; 2005 Apr; 166(4):1017-28. PubMed ID: 15793283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte growth factor gene therapy of liver cirrhosis in rats.
    Ueki T; Kaneda Y; Tsutsui H; Nakanishi K; Sawa Y; Morishita R; Matsumoto K; Nakamura T; Takahashi H; Okamoto E; Fujimoto J
    Nat Med; 1999 Feb; 5(2):226-30. PubMed ID: 9930873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats.
    Nakamura T; Sakata R; Ueno T; Sata M; Ueno H
    Hepatology; 2000 Aug; 32(2):247-55. PubMed ID: 10915731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of ethanol on hepatocyte growth factor-induced DNA synthesis and Ca2+ mobilization in rat hepatocytes.
    Saso K; Higashi K; Nomura T; Hoshino M; Ito M; Moehren G; Hoek JB
    Alcohol Clin Exp Res; 1996 Dec; 20(9 Suppl):330A-334A. PubMed ID: 8986232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
    Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
    Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of lysophosphatidic acid on proliferation of stellate cells and hepatocytes in culture.
    Ikeda H; Yatomi Y; Yanase M; Satoh H; Nishihara A; Kawabata M; Fujiwara K
    Biochem Biophys Res Commun; 1998 Jul; 248(2):436-40. PubMed ID: 9675156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
    Price JA; Kovach SJ; Johnson T; Koniaris LG; Cahill PA; Sitzmann JV; McKillop IH
    Hepatology; 2002 Nov; 36(5):1089-97. PubMed ID: 12395318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenobarbital suppresses growth and accelerates restoration of differentiation markers of primary culture rat hepatocytes in the chemically defined hepatocyte growth medium containing hepatocyte growth factor and epidermal growth factor.
    Miyazaki M; Mars WM; Runge D; Kim TH; Bowen WC; Michalopoulos GK
    Exp Cell Res; 1998 Jun; 241(2):445-57. PubMed ID: 9637786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.